随机对照试验作为康复中的证据来源:批判性分析
Sandra Schmitz1, Thorsten Meyer-Feil2
1Interdisciplinary Center of Health Sciences, Institute for Rehabilitation Medicine, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle, Germany - sandra.schmitz@uk-halle.de.
European journal of physical and rehabilitation medicine
|September 18, 2024
概括
随机对照试验 (RCT) 由于复杂的干预措施和整体目标,在康复中面临实施挑战. 需要进一步的研究来澄清RCT的功能和适用于各种康复环境中的应用.
科学领域:
- 康复医学 康复医学 康复医学
- 临床研究方法论 临床研究方法论
背景情况:
- 随机对照试验 (RCT) 对基于证据的医学至关重要,但在康复中面临实施挑战.
- 由于康复研究的实际困难,RCT的"黄金标准"地位受到质疑.
研究的目的:
- 检查限制RCT在康复实践中的适用性因素.
- 探索干预复杂性,方法严谨性和RCT适用性之间的关系.
- 在知识生成与干预合法化方面区分RCT的功能.
主要方法:
- 在康复中实施RCT的理论分析.
- 检查干预复杂性 (组件,措施,计划) 以及其对严格性的影响.
- 讨论RCT功能及其对研究设计选择的影响.
主要成果:
- 康复干预的复杂性和长期的整体目标对RCTs构成重大挑战.
- 风险试验中的方法严谨性受干预复杂性和控制条件/背景的能力的影响.
- 一个RCT的功能 (知识获取与合法化) 影响其适当性.
结论:
- 在康复中RCT的适用性受到治疗复杂性和目标的限制.
- 澄清干预水平和RCT功能对于适当的研究设计选择至关重要.
- 需要进一步的研究来指导RCT在康复中的有效实施.
相关概念视频
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:13Randomized Experiments
6.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.8K
01:12Hazard Ratio
92
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
92